Can the shingles shot protect aging immune systems?
NCT ID NCT05575830
Summary
This study is checking how well the newer shingles vaccine (Shingrix) works and how safe it is for people over 50 who are living with HIV and taking long-term medication. Researchers are comparing their immune response to that of healthy adults of the same age over one year. The goal is to see if the vaccine provides strong protection against shingles for this group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RZV VACCINE (SHINGRIX ®) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bern University Hospital (Inselspital)
Bern, Canton of Bern, 3010, Switzerland
-
CHU de Bordeaux - Hôpital Haut-Lévèque
Pessac, Gironde, 33604, France
-
Centre Hospitalier Universitaire Vaudoise (CHUV)
Lausanne, Canton of Vaud, 1011, Switzerland
-
Ente Ospedaliero Cantonale
Lugano, Canton Ticino, 6900, Switzerland
-
Hôpital Saint-André, CHU de Bordeaux
Bordeaux, Bordeaux, 33075, France
-
Kantonsspital
Sankt Gallen, Canton of St. Gallen, 9007, Switzerland
-
SMIT - Service de Maladies Infectieuses et Tropicales Le Tripode -Groupe Hospitalier Pellegrin
Bordeaux, France, 33000, France
-
University Hospital Basel
Basel, Basel, 4031, Switzerland
-
University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
-
University Hospitals of Geneva
Geneva, Canton of Geneva, 1205, Switzerland
Conditions
Explore the condition pages connected to this study.